A novel strategy to achieve effective drug delivery: exploit cells as carrier combined with nanoparticles

References

• Adams CF, Pickard MR, Chari DM. (2013). Magnetic nanoparticle mediated transfection of neural stem cell suspension cultures is enhanced by applied oscillating magnetic fields. Nanomed: Nanotechnol Biol Med 9:737–41
   PubMed Web of Science ®Google Scholar
• Afergan E, Epstein H, Dahan R, et al. (2008). Delivery of serotonin to the brain by monocytes following phagocytosis of liposomes. J Control Release 132:84–90
   PubMed Web of Science ®Google Scholar
• Ahn S, Jung SY, Seo E, et al. (2011). Gold nanoparticle-incorporated human red blood cells (RBCs) for X-ray dynamic imaging. Biomaterials 32:7191–9
   PubMed Web of Science ®Google Scholar
• Albanese A, Tang PS, Chan WC. (2012). The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng 14:1–16
   PubMed Web of Science ®Google Scholar
• Anselmo AC, Gupta V, Zern BJ, et al. (2013). Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells. ACS Nano 7:11129–37
   PubMed Web of Science ®Google Scholar
• Anselmo AC, Mitragotri S. (2014). Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles. J Control Release 190:531–41
   PubMed Web of Science ®Google Scholar
• Behfar A, Crespo-Diaz R, Terzic A, et al. (2014). Cell therapy for cardiac repair-lessons from clinical trials. Nat Rev Cardiol 11:232–46
   PubMed Web of Science ®Google Scholar
• Bexell D, Svensson A, Bengzon J. (2013). Stem cell-based therapy for malignant glioma. Cancer Treatment Rev 39:358–65
   PubMed Web of Science ®Google Scholar
• Bhateria M, Rachumallu R, Singh R, et al. (2014). Erythrocytes-based synthetic delivery systems: transition from conventional to novel engineering strategies. Expert Opin Drug Deliv 11:1219–36
   PubMed Web of Science ®Google Scholar
• Borlongan CV, Glover LE, Tajiri N, et al. (2011). The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disorders. Prog Neurobiol 95:213–28
   PubMed Web of Science ®Google Scholar
• Bradley AJ, Murad KL, Regan KL, et al. (2002). Biophysical consequences of linker chemistry and polymer size on stealth erythrocytes: size does matter. Biochim Biophys Acta 1561:147–58
   PubMed Web of Science ®Google Scholar
• Briones E, Colino CI, Millan CG, et al. (2009). Increasing the selectivity of amikacin in rat peritoneal macrophages using carrier erythrocytes. Eur J Pharm Sci 38:320–4
   PubMed Web of Science ®Google Scholar
• Brynskikh AM, Zhao Y, Mosley RL, et al. (2010). Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson's disease. Nanomedicine (Lond) 5:379–96
   PubMed Web of Science ®Google Scholar
• Chambers E, Mitragotri S. (2004). Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes. J Control Release 100:111–19
   PubMed Web of Science ®Google Scholar
• Chambers E, Mitragotri S. (2007). Long circulating nanoparticles via adhesion on red blood cells: mechanism and extended circulation. Exp Biol Med (Maywood) 232:958–66
   PubMed Web of Science ®Google Scholar
• Chen J, Li Y, Chopp M. (2000). Intracerebral transplantation of bone marrow with BDNF after MCAo in rat. Neuropharmacology 39:711–16
   PubMed Web of Science ®Google Scholar
• Chen Y, Liu L. (2012). Modern methods for delivery of drugs across the blood–brain barrier. Adv Drug Deliv Rev 64:640–65
   PubMed Web of Science ®Google Scholar
• Choi MR, Bardhan R, Stanton-Maxey KJ, et al. (2012). Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse. Cancer Nanotechnol 3:47–54
   PubMedGoogle Scholar
• Choi MR, Stanton-Maxey KJ, Stanley JK, et al. (2007). A cellular Trojan horse for delivery of therapeutic nanoparticles into tumors. Nano Lett 7:3759–65
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. (2002). Inflammation and cancer. Nature 420:860–7
   PubMed Web of Science ®Google Scholar
• Dar A, Kollet O, Lapidot T. (2006). Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice. Exp Hematol 34:967–75
   PubMed Web of Science ®Google Scholar
• De Souza R, Zahedi P, Allen CJ, et al. (2010). Polymeric drug delivery systems for localized cancer chemotherapy. Drug Deliv 17:365–75
   PubMed Web of Science ®Google Scholar
• Deng NH, Wang L, He QC, et al. (2016). PEGylation alleviates the non-specific toxicities of Alpha-Momorcharin and preserves its antitumor efficacy in vivo. Drug Deliv 23:95–100
   PubMed Web of Science ®Google Scholar
• Denzer K, Kleijmeer MJ, Heijnen HF, et al. (2000). Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci 113:3365–74
   PubMed Web of Science ®Google Scholar
• El Andaloussi S, Lakhal S, Mäger I, et al. (2013). Exosomes for targeted siRNA delivery across biological barriers. Adv Drug Deliv Rev 65:391–7
   PubMed Web of Science ®Google Scholar
• Eniola AO, Hammer DA. (2003). Artificial polymeric cells for targeted drug delivery. J Control Release 87:15–22
   PubMed Web of Science ®Google Scholar
• Eniola AO, Rodgers SD, Hammer DA. (2002). Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes. Biomaterials 23:2167–77
   PubMed Web of Science ®Google Scholar
• Felsenstein KM, Candelario KM, Steindler DA, et al. (2014). Regenerative medicine in Alzheimer's disease. Transl Res 163:432–8
   PubMed Web of Science ®Google Scholar
• Firor AE, Jares A, Ma Y. (2015). From humble beginnings to success in the clinic: chimeric antigen receptor-modified T-cells and implications for immunotherapy. Exp Biol Med (Maywood) 240:1087–98
   PubMed Web of Science ®Google Scholar
• Gao X, Qian J, Zheng S, et al. (2013). Up-regulating blood brain barrier permeability of nanoparticles via multivalent effect. Pharm Res 30:2538–48
   PubMed Web of Science ®Google Scholar
• Garg T, Bhandari S, Rath G, et al. (2015). Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor. J Drug Target 23:865–87
   PubMed Web of Science ®Google Scholar
• Gradauer K, Barthelmes J, Vonach C, et al. (2013). Liposomes coated with thiolated chitosan enhance oral peptide delivery to rats. J Control Release 172:872–8
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M. (2010). Immunity, inflammation, and cancer. Cell 140:883–99
   PubMed Web of Science ®Google Scholar
• Gutierrez Millan C, Zarzuelo Castaneda A, Sayalero Marinero ML, et al. (2004). Factors associated with the performance of carrier erythrocytes obtained by hypotonic dialysis. Blood Cells Mol Dis 33:132–40
   PubMed Web of Science ®Google Scholar
• Hamidi M, Zarei N, Zarrin AH, et al. (2007). Preparation and in vitro characterization of carrier erythrocytes for vaccine delivery. Int J Pharm 338:70–8
   PubMed Web of Science ®Google Scholar
• Haney MJ, Klyachko NL, Zhao Y, et al. (2015). Exosomes as drug delivery vehicles for Parkinson's disease therapy. J Control Release 207:18–30
   PubMed Web of Science ®Google Scholar
• He H, Ye J, Wang Y, et al. (2014). Cell-penetrating peptides meditated encapsulation of protein therapeutics into intact red blood cells and its application. J Control Release 176:123–32
   PubMed Web of Science ®Google Scholar
• He S, Zhou Z, Li L, et al. (2016). Comparison of active and passive targeting of doxorubicin for somatostatin receptor 2 positive tumor models by octreotide-modified HPMA copolymer-doxorubicin conjugates. Drug Deliv 23:285–96
   PubMed Web of Science ®Google Scholar
• Hu CM, Zhang L, Aryal S, et al. (2011). Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform . Proc Natl Acad Sci USA 108:10980–5
   PubMed Web of Science ®Google Scholar
• Hu C-MJ, Fang RH, Zhang L. (2012). Erythrocyte-inspired delivery systems. Adv Healthcare Mater 1:537–47
   Web of Science ®Google Scholar
• Hu Q, Sun W, Qian C, et al. (2015). Anticancer platelet-mimicking nanovehicles. Adv Mater Weinheim 27:7043–50
   PubMed Web of Science ®Google Scholar
• Hu YL, Fu YH, Tabata Y, et al. (2010). Mesenchymal stem cells: a promising targeted-delivery vehicle in cancer gene therapy. J Control Release 147:154–62
   PubMed Web of Science ®Google Scholar
• Huang B, Tabata Y, Gao JQ. (2012). Mesenchymal stem cells as therapeutic agents and potential targeted gene delivery vehicle for brain diseases. J Control Release 162:464–73
   PubMed Web of Science ®Google Scholar
• Huang WC, Chiang WH, Cheng YH, et al. (2015). Tumortropic monocyte-mediated delivery of echogenic polymer bubbles and therapeutic vesicles for chemotherapy of tumor hypoxia. Biomaterials 71:71–83
   PubMed Web of Science ®Google Scholar
• Huang X, Zhang F, Wang H, et al. (2013). Mesenchymal stem cell-based cell engineering with multifunctional mesoporous silica nanoparticles for tumor delivery. Biomaterials 34:1772–80
   PubMed Web of Science ®Google Scholar
• Ihler GM, Glew RH, Schnure FW. (1973). Enzyme loading of erythrocytes. Proc Natl Acad Sci USA 70:2663–6
   PubMed Web of Science ®Google Scholar
• Ikeda H, Shiku H. (2015). Adoptive immunotherapy of cancer utilizing genetically engineered lymphocytes. Cancer Immunol Immunother 64:903–9
   PubMed Web of Science ®Google Scholar
• Ishida T, Kiwada H. (2013). Anti-polyethyleneglycol antibody response to PEGylated substances. Biol Pharm Bull 36:889–91
   PubMed Web of Science ®Google Scholar
• Jain S, Mishra V, Singh P, et al. (2003). RGD-anchored magnetic liposomes for monocytes/neutrophils-mediated brain targeting. Int J Pharm 261:43–55
   PubMed Web of Science ®Google Scholar
• Kang S, Park T, Chen X, et al. (2011). Tunable physiologic interactions of adhesion molecules for inflamed cell-selective drug delivery. Biomaterials 32:3487–98
   PubMed Web of Science ®Google Scholar
• Kwon YM, Chung HS, Moon C, et al. (2009). l-Asparaginase encapsulated intact erythrocytes for treatment of acute lymphoblastic leukemia (ALL). J Control Release 139:182–9
   PubMed Web of Science ®Google Scholar
• Lameijer MA, Tang J, Nahrendorf M, et al. (2013). Monocytes and macrophages as nanomedicinal targets for improved diagnosis and treatment of disease. Expert Rev Mol Diagn 13:567–80
   PubMed Web of Science ®Google Scholar
• Lee S. (2014). Monocytes: a novel drug delivery system targeting atherosclerosis. J Drug Target 22:138–45
   PubMed Web of Science ®Google Scholar
• Lewis CE, Pollard JW. (2006). Distinct role of macrophages in different tumor microenvironments. Cancer Res 66:605–12
   PubMed Web of Science ®Google Scholar
• Luk BT, Zhang L. (2015). Cell membrane-camouflaged nanoparticles for drug delivery. J Control Release 220:600–7
   PubMed Web of Science ®Google Scholar
• Ma N, Ma C, Li C, et al. (2013). Influence of nanoparticle shape, size, and surface functionalization on cellular uptake. J Nanosci Nanotechnol 13:6485–98
   PubMed Web of Science ®Google Scholar
• Menon LG, Kelly K, Yang HW, et al. (2009). Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy. Stem Cells 27:2320–30
   PubMed Web of Science ®Google Scholar
• Muller FJ, Snyder EY, Loring JF. (2006). Gene therapy: can neural stem cells deliver? Nat Rev Neurosci 7:75–84
   PubMed Web of Science ®Google Scholar
• Omolola Eniola A, Hammer DA. (2005). In vitro characterization of leukocyte mimetic for targeting therapeutics to the endothelium using two receptors. Biomaterials 26:7136–44
   PubMed Web of Science ®Google Scholar
• Pang L, Qin J, Han L, et al. (2016). Exploiting macrophages as targeted carrier to guide nanoparticles into glioma. Oncotarget 7:37081–91
   PubMed Web of Science ®Google Scholar
• Parodi A, Quattrocchi N, van de Ven AL, et al. (2013). Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nat Nanotechnol 8:61–8
   PubMed Web of Science ®Google Scholar
• Penberthy TW, Jiang Y, Graves DT. (1997). Leukocyte adhesion molecules. Crit Rev Oral Biol Med 8:380–8
   PubMedGoogle Scholar
• Peng LH, Tsang SY, Tabata Y, et al. (2012). Genetically-manipulated adult stem cells as therapeutic agents and gene delivery vehicle for wound repair and regeneration. J Control Release 157:321–30
   PubMed Web of Science ®Google Scholar
• Peng LH, Zhang YH, Han LJ, et al. (2015). Cell membrane capsules for encapsulation of chemotherapeutic and cancer cell targeting in vivo. ACS Appl Mater Interfaces 7:18628–37
   PubMed Web of Science ®Google Scholar
• Porada CD, Almeida-Porada G. (2010). Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery. Adv Drug Deliv Rev 62:1156–66
   PubMed Web of Science ®Google Scholar
• Puentes A, Garcia J, Vera R, et al. (2000). Serine repeat antigen peptides which bind specifically to red blood cells. Parasitol Int 49:105–17
   PubMed Web of Science ®Google Scholar
• Qin J, Chen D, Hu H, et al. (2007). Body distribution of RGD-mediated liposome in brain-targeting drug delivery. Yakugaku Zasshi 127:1497–501
   PubMed Web of Science ®Google Scholar
• Qin J, Yang X, Mi J, et al. (2014a). Enhanced antidepressant-like effects of the macromolecule trefoil factor 3 by loading into negatively charged liposomes. Int J Nanomedicine 9:5247–57
   PubMed Web of Science ®Google Scholar
• Qin J, Yang X, Zhang RX, et al. (2015). Monocyte mediated brain targeting delivery of macromolecular drug for the therapy of depression. Nanomedicine 11:391–400
   PubMed Web of Science ®Google Scholar
• Qin J, Zhang RX, Li JL, et al. (2014b). cRGD mediated liposomes enhanced antidepressant-like effects of edaravone in rats. Eur J Pharm Sci 58:63–71
   PubMed Web of Science ®Google Scholar
• Record M, Carayon K, Poirot M, et al. (2014). Exosomes as new vesicular lipid transporters involved in cell–cell communication and various pathophysiologies. Biochim Biophys Acta (BBA) – Mol Cell Biol Lipids 1841:108–20
   PubMed Web of Science ®Google Scholar
• Roger M, Clavreul A, Venier-Julienne MC, et al. (2010). Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors. Biomaterials 31:8393–401
   PubMed Web of Science ®Google Scholar
• Roger M, Clavreul A, Venier-Julienne MC, et al. (2011). The potential of combinations of drug-loaded nanoparticle systems and adult stem cells for glioma therapy. Biomaterials 32:2106–16
   PubMed Web of Science ®Google Scholar
• Samanta A, Banerjee S, Liu Y. (2015). DNA nanotechnology for nanophotonic applications. Nanoscale 7:2210–20
   PubMed Web of Science ®Google Scholar
• Sharma RR, Pollock K, Hubel A, et al. (2014). Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices. Transfusion 54:1418–37
   PubMed Web of Science ®Google Scholar
• Sriraman SK, Geraldo V, Luther E, et al. (2015). Cytotoxicity of PEGylated liposomes co-loaded with novel pro-apoptotic drug NCL-240 and the MEK inhibitor cobimetinib against colon carcinoma in vitro. J Control Release 220:160–8
   PubMed Web of Science ®Google Scholar
• Steinfeld U, Pauli C, Kaltz N, et al. (2006). T lymphocytes as potential therapeutic drug carrier for cancer treatment. Int J Pharm 311:229–36
   PubMed Web of Science ®Google Scholar
• Stephan MT, Moon JJ, Um SH, et al. (2010). Therapeutic cell engineering with surface-conjugated synthetic nanoparticles. Nat Med 16:1035–41
   PubMed Web of Science ®Google Scholar
• Suk JS, Xu Q, Kim N, et al. (2015). PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev 99:28–51
   PubMed Web of Science ®Google Scholar
• Sun D, Zhuang X, Zhang S, et al. (2013). Exosomes are endogenous nanoparticles that can deliver biological information between cells. Adv Drug Deliv Rev 65:342–7
   PubMed Web of Science ®Google Scholar
• Taghizadeh B, Taranejoo S, Monemian SA, et al. (2015). Classification of stimuli-responsive polymers as anticancer drug delivery systems. Drug Deliv 22:145–55
   PubMed Web of Science ®Google Scholar
• Tao Y, Ning M, Dou H. (2013). A novel therapeutic system for malignant glioma: nanoformulation, pharmacokinetic, and anticancer properties of cell-nano-drug delivery. Nanomed: Nanotechnol Biol Med 9:222–32
   PubMed Web of Science ®Google Scholar
• Thery C, Ostrowski M, Segura E. (2009). Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 9:581–93
   PubMed Web of Science ®Google Scholar
• Tian Y, Li S, Song J, et al. (2014). A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials 35:2383–90
   PubMed Web of Science ®Google Scholar
• Villa CH, Pan DC, Zaitsev S, et al. (2015). Delivery of drugs bound to erythrocytes: new avenues for an old intravascular carrier. Ther Deliv 6:795–826
   PubMed Web of Science ®Google Scholar
• Wang Y, Fan W, Dai X, et al. (2014). Enhanced tumor delivery of gemcitabine via PEG-DSPE/TPGS mixed micelles. Mol Pharm 11:1140–50
   PubMed Web of Science ®Google Scholar
• Wilson WR, Hay MP. (2011). Targeting hypoxia in cancer therapy. Nat Rev Cancer 11:393–410
   PubMed Web of Science ®Google Scholar
• Wong D, Prameya R, Dorovini-Zis K. (2007). Adhesion and migration of polymorphonuclear leukocytes across human brain microvessel endothelial cells are differentially regulated by endothelial cell adhesion molecules and modulate monolayer permeability. J Neuroimmunol 184:136–48
   PubMed Web of Science ®Google Scholar
• Yamashita F, Hashida M. (2013). Pharmacokinetic considerations for targeted drug delivery. Adv Drug Deliv Rev 65:139–47
   PubMed Web of Science ®Google Scholar
• Yang F, Cho SW, Son SM, et al. (2010). Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles. Proc Natl Acad Sci USA 107:3317–22
   PubMed Web of Science ®Google Scholar
• Yin F, Guo L, Meng CY, et al. (2014). Transplantation of mesenchymal stem cells exerts anti-apoptotic effects in adult rats after spinal cord ischemia-reperfusion injury. Brain Res 1561:1–10
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chan HF, Leong KW. (2013). Advanced materials and processing for drug delivery: the past and the future. Adv Drug Deliv Rev 65:104–20
   PubMed Web of Science ®Google Scholar